• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconJohnson & Johnson

Johnson & Johnson

Page 12 of 18
How 3 of biopharma’s most powerful women are building public trust during COVID
ConferencesHow 3 of biopharma’s most powerful women are building public trust during COVID
By Sy MukherjeeSeptember 29, 2020
Portrait of Pascal Soriot, AstraZeneca CEO
HealthUnder fire, AstraZeneca CEO defends transparency of COVID-19 vaccine trials
By Jeremy KahnSeptember 24, 2020
Oxford-Vaccine-Trials-Kaiser-Health-News
HealthOxford’s COVID vaccine deal with AstraZeneca raises concerns about access and pricing
By Jay Hancock, Kaiser Health NewsAugust 24, 2020
Johnson & Johnson just invested in a telemedicine startup. Here’s why
TechJohnson & Johnson just invested in a telemedicine startup. Here’s why
By Jonathan VanianAugust 14, 2020
Johnson & Johnson antidepressant spray approved for treating those at risk of suicide
HealthJohnson & Johnson antidepressant spray approved for treating those at risk of suicide
By Cynthia Koons and BloombergAugust 3, 2020
Brainstorm Health 2020-Alex Gorsky
NewslettersJohnson & Johnson’s CEO on building trust for a coronavirus vaccine
By Sy MukherjeeJuly 9, 2020
Brainstorm Health 2020-Alex Gorsky
NewslettersJ&J’s CEO says creating a vaccine is only ‘part of the puzzle’
By Katherine Dunn and Alan MurrayJuly 9, 2020
5 companies to keep an eye on following the world’s largest cancer conference
Health5 companies to keep an eye on following the world’s largest cancer conference
By Sy MukherjeeJune 3, 2020
Paul Hudson, chief executive officer of Sanofi, gestures as he speaks during a panel session on the sidelines of the China International Import Expo (CIIE) in Shanghai, China, on Tuesday, Nov. 5, 2019. The CIIE -- now in its second year -- is designed to showcase the countrys desire to shift its economy toward consumption by buying more foreign goods. Photographer: Qilai Shen/Bloomberg via Getty Images
NewslettersBig pharma’s big chance
By Katherine Dunn and Alan MurrayApril 3, 2020
J&J coronavirus vaccine
NewslettersJohnson & Johnson CEO on the race to make a coronavirus vaccine
By Katherine Dunn and Alan MurrayMarch 31, 2020
J&J coronavirus
NewslettersJ&J’s coronavirus vaccine could hit the market by 2021
By Sy MukherjeeMarch 30, 2020
Johnson & Johnson hopes to have its promising coronavirus vaccine approved by early 2021
HealthJohnson & Johnson hopes to have its promising coronavirus vaccine approved by early 2021
By Sy MukherjeeMarch 30, 2020
Apple J&J heart study
NewslettersApple and Johnson & Johnson team up on heart study
By Sy MukherjeeFebruary 26, 2020
fortune global forum
NewslettersThe CEO’s Job Is Tougher Than Ever
By Aaron Pressman and Adam LashinskyNovember 18, 2019
What the Sackler Offer and the J&J Opioid Verdict Tell Us About the Next Big Test for Drugmakers—an Ohio Trial in October
FinanceWhat the Sackler Offer and the J&J Opioid Verdict Tell Us About the Next Big Test for Drugmakers—an Ohio Trial in October
By Ellen FlorianAugust 27, 2019
1...
  • 10
  • 11
  • 12
  • 13
  • 14
...18
Most Popular
Success
Apple cofounder Ronald Wayne—whose stake would be worth up to $400 billion had he not sold it in 1976—says that at 91, he has no regretsplaceholder alt text
By Preston ForeApril 27, 2026
Big Tech
Google Cloud revenue is now 18% of Alphabet's business. Is this the beginning of the end of Google's search identity?placeholder alt text
By Alexei OreskovicApril 29, 2026
Banking
‘They left me no choice’: Powell isn’t going anywhere—blocking Trump from another Fed appointeeplaceholder alt text
By Eva RoytburgApril 29, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.